Effects of the SGLT‐2 inhibitor dapagliflozin on glomerular and tubular injury markers

The mechanisms by which SGLT‐2 inhibitors lower albuminuria are incompletely understood. We assessed in a post‐hoc analysis of a cross‐over trial the effects of the SGLT2 inhibitor dapagliflozin on glomerular markers (IgG to IgG4 and IgG to albumin), tubular markers (urinary KIM‐1, NGAL and LFABP) a...

Descripción completa

Detalles Bibliográficos
Autores principales: Dekkers, Claire C. J., Petrykiv, Sergei, Laverman, Gozewijn D., Cherney, David Z., Gansevoort, Ron T., Heerspink, Hiddo J. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2018
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055757/
https://www.ncbi.nlm.nih.gov/pubmed/29573529
http://dx.doi.org/10.1111/dom.13301

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055757/
https://www.ncbi.nlm.nih.gov/pubmed/29573529
http://dx.doi.org/10.1111/dom.13301

Ejemplares similares